特集論文
Mass Spectrometry in Therapeutic Drug Monitoring
島津評論 74〔1・2〕 85～99 (2017.9)
Abstract
Therapeutic drug monitoring has become a pivotal tool for clinicians to individualize therapy, to check observance and maximize response while lowering side effects. Highly accurate and high-throughput analytical technologies are necessary. Liquid chromatography-tandem mass spectrometry has become a major tool to achieve these goals because of its unique capabilities. To fully take its place in clinical laboratories, LC-MS/MS need to adapt to clinical laboratory needs. For this, automation solutions now exist. A general presentation of LC-MS/MS and its advantages over other analytical technologies are presented as well as practical examples of automation solution.
Keywords : Therapeutic drug monitoring, Liquid chromatography-tandem mass spectrometry, Immunosuppressants, Anticonvulsants, Automation
1MS Business Unit, Life Science Business Department, Analytical & Measuring Instruments Division, Shimadzu Corporation, Kyoto, Japan
※島津評論に掲載されている情報は、論文発表当時のものです。記載されている製品は、既に取り扱っていない場合もございますので、ご了承ください。